Foropafant
|
|
|
- CAS-Nr.
- 136468-36-5
- Englisch Name:
- Foropafant
- Synonyma:
- SR 27417;Foropafant;Faropafant;SR 27417 >=98% (HPLC);Foropafant, 10 mM in DMSO;inhibit,SR-27417,SR 27417,Foropafant,Inhibitor;N-(2-Dimethylaminoethyl)-N-(3-pyridylmethyl)-4-(2,4,6-triisopropylphenyl)thiazol-2-amine;4-(2,4,6-Triisopropylphenyl)-N-[2-(dimethylamino)ethyl]-N-(3-pyridylmethyl)thiazol-2-amine;N1,N1-Dimethyl-N2-(pyridin-3-ylmethyl)-N2-(4-(2,4,6-triisopropylphenyl)thiazol-2-yl)ethane-1,2;N1,N1-Dimethyl-N2-(pyridin-3-ylmethyl)-N2-(4-(2,4,6-triisopropylphenyl)thiazol-2-yl)ethane-1,2-di
- CBNumber:
- CB41117105
- Summenformel:
- C28H40N4S
- Molgewicht:
- 464.71
- MOL-Datei:
- 136468-36-5.mol
|
Foropafant Eigenschaften
- Siedepunkt:
- 571.6±60.0 °C(Predicted)
- Dichte
- 1.065±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,2-8°C
- L?slichkeit
- DMSO: soluble5mg/mL (clear solution, warmed)
- pka
- 8.75±0.28(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to beige
- InChI
- 1S/C28H40N4S/c1-19(2)23-14-24(20(3)4)27(25(15-23)21(5)6)26-18-33-28(30-26)32(13-12-31(7)8)17-22-10-9-11-29-16-22/h9-11,14-16,18-21H,12-13,17H2,1-8H3
- InChIKey
- VVBFISAUNSXQGZ-UHFFFAOYSA-N
- SMILES
- CC(C)c1cc(C(C)C)c(-c2csc(n2)N(CCN(C)C)Cc3cccnc3)c(c1)C(C)C
Foropafant Chemische Eigenschaften,Einsatz,Produktion Methoden
Biochem/physiol Actions
SR 27417 is a long-acting, highly potent, specific competitive platelet-activating factor (PAF) receptor antagonist.
Foropafant Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Foropafant Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 40)Lieferanten
- Foropafant
- 4-(2,4,6-Triisopropylphenyl)-N-[2-(dimethylamino)ethyl]-N-(3-pyridylmethyl)thiazol-2-amine
- SR 27417
- N-(2-Dimethylaminoethyl)-N-(3-pyridylmethyl)-4-(2,4,6-triisopropylphenyl)thiazol-2-amine
- N1,N1-dimethyl-N2-(pyridin-3-ylmethyl)-N2-(4-(2,4,6-triisopropylphenyl)thiazol-2-yl)ethane-1,2-diamine
- N1,N1-Dimethyl-N2-(pyridin-3-ylmethyl)-N2-(4-(2,4,6-triisopropylphenyl)thiazol-2-yl)ethane-1,2-di
- Faropafant
- N,N-Dimethyl-N′-(3-pyridinylmethyl)-N′-[4-[2,4,6-tris(1-methylethyl)phenyl]-2-thiazolyl]-1,2-ethanediamine
- N1,N1-Dimethyl-N2-(3-pyridinylmethyl)-N2-[4-[2,4,6-tris(1-methylethyl)phenyl]-2-thiazolyl]-1,2-ethanediamine
- N1,N1-Dimethyl-N2-(pyridin-3-ylmethyl)-N2-(4-(2,4,6-triisopropylphenyl)thiazol-2-yl)ethane-1,2
- SR 27417 >=98% (HPLC)
- 1,2-Ethanediamine, N1,N1-dimethyl-N2-(3-pyridinylmethyl)-N2-[4-[2,4,6-tris(1-methylethyl)phenyl]-2-thiazolyl]-
- inhibit,SR-27417,SR 27417,Foropafant,Inhibitor
- Foropafant, 10 mM in DMSO
- 136468-36-5
- C28H40N4S
